Empowering Medicare Recipients to Increase Program Efficiencies:
A People First Plan
by Anuja Roy and Kome Okposo

Proliferation of non-traditional competitors and stakeholders, including non-traditional flow of innovation, and a general perception of inflated cost of healthcare, challenge the legacy model of drug development and commercialization.

Hopes that the UK-US trade agreement would give some clarity on the situation for pharmaceuticals – one of the UK's biggest export categories – proved optimistic.